ejyceh.wordpress.com
million in goodwill. The Buford, Ga.-based surgical products and cancer treatments company is expected to releasw its fourth quarter earningson Feb. 19. Theragenicws said it will make no comments about the chargre until its earnings are Theragenics (NYSE: TGX) is “in the process of finalizinbg the amount of the charge, but it is anticipated to include all or substantially all of the goodwillo recorded on its balance sheet, whicgh totaled $67.9 million,” the company said in a Certain other intangible assets with a carrying value of $5.
8 millioj are also expected to incur impairment chargezs of up to one-half of their recorded The non-cash charges, Theragenics will not affect the company’s liquidity, cash flowds from operating activities, or future operations. Under U.S. accountintg rules, goodwill and other intangiblee assets arenot amortized, but tested for impairment at least Factors considered in determininvg fair value include, the company’s markeg capitalization, the market values of its reporting unitzs based on market multiples for comparablre companies, and discount rates that reflect not only the firm’xs businesses, but also the overall economi environment.
“The extended decline in [Theragenics] share price and the uncertaintie and deterioration in overall macroeconomixc conditions through the currenrt date have had a materialp impact on the impairment test for goodwillp and other intangible assets withindefinite lives,” the companyu said. Theragenics shares have tumbled nearly 70 percent in thepast
No comments:
Post a Comment